Hostname: page-component-89b8bd64d-9prln Total loading time: 0 Render date: 2026-05-07T09:50:37.575Z Has data issue: false hasContentIssue false
  • English
  • Français

Reviewer Comment on Randall et al. “Calcitonin Gene-Related Peptide Inhibitor Use in 2018–2023: A Retrospective Cohort Study Across Six Canadian Provinces”

Published online by Cambridge University Press:  20 January 2026

Ioana Medrea Open the ORCID record for Ioana Medrea [Opens in a new window]
Ioana Medrea*
Affiliation:
Women’s College Hospital, Division of Neurology, University of Toronto , Toronto, ON, Canada
*
Email: ioana.medrea@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Reviewer Comment
Information
Canadian Journal of Neurological Sciences , First View , pp. 1
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Tepper, SJ. History and review of anti-calcitonin gene-related peptide (CGRP) therapies: from translational research to treatment. Headache J Head Face Pain. 2018;58:238–275.10.1111/head.13379CrossRefGoogle Scholar
Medrea, I, Cooper, P, Langman, M, et al. Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis. Can J Neurol Sci. 2024;7:1–23.Google Scholar
Randall, JR, Martins, KJB, Luu, H, et al. Calcitonin gene-related peptide inhibitor use in 2018-2023: a retrospective cohort study across six Canadian provinces. Can J Neurol Sci. 2025:1–26.10.1017/cjn.2025.10506CrossRefGoogle ScholarPubMed
Hepp, Z, Dodick, DW, Varon, SF, Gillard, P, Hansen, RN, Devine, EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 2015;35:478–488.10.1177/0333102414547138CrossRefGoogle ScholarPubMed
Hepp, Z, Dodick, DW, Varon, SF, et al. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia. 2017;37:470–485.10.1177/0333102416678382CrossRefGoogle Scholar